Abstract:Objective To study the value of relative cerebral blood flow(rCBF)changes in patients with amnestic-type mild cognitive impairment (aMCI)and mild Alzheimer disease(AD) using MRI pulsed arterial spin labeling(PASL).Methods A prospective study recruited 37 aMCI patients (aMCI group),30 mild AD patients(mild AD group) and 30 healthy volunteers (normal control group) from March 2011 to December 2013,MRI using PASL for cerebral perfusion imaging was performed and data of rCBF were collected.Taking age as covariate,analysis of variance (ANONA)was carried out to assess the difference of rCBF among all the three groups,then Bonferroni was done between every two groups.A follow-up examination using PASL was performed in the seventeen patients of the aMCI group.And paired t-test was used for comparing the longitudinal change of their rCBF data.Results Compared with the normal control group,the aMCI group showed significant increase of rCBF in bilateral posterior cingulate cortices and precuneus (cluster number 2 785,P＜0.05).While the mild AD group showed decrease of rCBF in the left inferior and superior parietal lobes,the angular,middle frontal lobe,as well as the right superior temporal lobe (cluster number 3 459-5 206,P＜0.05).When compared with the aMCI group,the mild AD group showed regional hypoperfusion in bilateral middle frontal lobes,the left precuneus,the right postcentral and inferior parietal lobe (cluster number 3 236-19 863,P＜0.05).In the longitudinal study of the 17 aMCI patients,an increased rCBF was found to coexist with reduced rCBF in the left inferior frontal and lateral occipital cortex,bilateral frontal poles and paracingulate gyrus,with hyperperfusion dominated.Increased rCBF was also detected in the left temporal lobe,the angular gyrus and precuneus,while decreased rCBF was present in the left putamen,the operculum and right corpus callosum (P＜0.05).Conclusions ASL perfusion imaging is a valuable method for dynamic monitoring of the cerebral perfusion changes in aMCI and AD patients.PASL will assist in finding a useful imaging biomarker for early diagnosis of AD.

MRI Evaluation of Cerebral Perfusion Changes in Patients with MELAS Syndrome

MRI, ASL and 1H-MRS features of MELAS syndrome

Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome--xenon CT and PET study

Reversible Dilation of Cerebral Macrovascular Changes in MELAS Episodes

Differential diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) and ischemic stroke using 3D pseudocontinuous arterial spin labeling

Evaluation of Vascular Autoregulation in Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis,and Stroke-Like Episodes Patients

Quantitative Measurement of Cerebral Oxygen Extraction Fraction Using MRI in Patients with MELAS

MR Evaluation of Cerebral Oxygen Metabolism and Blood Flow in Stroke-Like Episodes of MELAS

MRI evaluation of cerebral perfusion change in pediatric patients with Leigh's syndrome

Application of MRI/MRS in differential diagnosis of MELAS syndrome and stroke

Metabolic abnormality in acute stroke-like lesion and its relationship with focal cerebral blood flow in patients with MELAS: Evidence from proton MR spectroscopy and arterial spin labeling

Combined Application of DWI MRS and CASL-PWI for Diagnosis of MELAS

MR imaging and MR spectroscopy features of MELAS and their clinical values

Apparent Diffusion Coefficients of Metabolites in Patients with MELAS Using Diffusion-Weighted MR Spectroscopy

Altered spontaneous brain activity at attack and remission stages in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): Beyond stroke-like lesions

The MRI findings of mitochondrial encephalomyopathy,lactic acidosis and stroke-like episodes

Application of Cerebral MR Perfusion Imaging Using Pulsed Arterial Spin Labeling Technique in Patients with Amnestic-Type Mild Cognitive Impairment and Mild Alzheimer Disease

MRI Findings of MELAS

The Technique of MR Perfusion and Its Application in Evaluating Cerebral Astrocytoma

The appearance of ADCs in the non-affected areas of the patients with MELAS

Reversible brain dysfunction in MELAS: MEG, and 1H MRS analysis